Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT01894126
Collaborator
National Institutes of Health (NIH) (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH), University of Nairobi (Other), Kenyatta National Hospital (Other)
300
1
3

Study Details

Study Description

Brief Summary

With the increased prevalence of cellular phones, mobile technology provides an important tool to reach underserved populations in low to middle income countries. mHealth interventions offer promise to improve maternal child health throughout the reproductive health continuum if they contribute to increasing skilled birth attendance, family planning and exclusive breastfeeding. We propose a randomized clinical trial to determine effect of using mobile phones to deliver SMS (one-way) versus an interactive SMS dialogue (two-way) on uptake of reproductive and neonatal health services and maternal and infant outcomes

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Two-way SMS Dialogue
  • Behavioral: One-way SMS Messaging
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WACh) in Kenya: A Randomized Control Trial
Study Start Date :
Jul 1, 2013
Actual Primary Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Two-way SMS dialogue

Women will receive SMS messages with prompts to reply. They will have the ability to text back to the system and both respond to and initiate SMS dialogue

Behavioral: Two-way SMS Dialogue

Experimental: One-way SMS Messaging

Women will receive scheduled one-way SMS messages

Behavioral: One-way SMS Messaging

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Contraceptive uptake [10 weeks postpartum; 24 weeks postpartum]

  2. Facility Delivery [Postpartum]

  3. Exclusive Breastfeeding [24 weeks postpartum]

Secondary Outcome Measures

  1. ANC attendance [Postpartum]

  2. Infant Immunizations [Six months postpartum]

  3. Maternal mortality [6 months postpartum]

  4. Infant mortality [Six months postpartum]

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pregnant

  • Access to a mobile phone

  • Able to read SMS messages

  • Willing to receive SMS messages

Exclusion Criteria:
  • Unwilling or unable to meet inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mathare North Health Centre Nairobi Kenya

Sponsors and Collaborators

  • University of Washington
  • National Institutes of Health (NIH)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of Nairobi
  • Kenyatta National Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jennifer Unger, Assistant Professor, University of Washington
ClinicalTrials.gov Identifier:
NCT01894126
Other Study ID Numbers:
  • K12HD001264-14UNGER
  • K12HD001264-14
First Posted:
Jul 9, 2013
Last Update Posted:
Nov 9, 2016
Last Verified:
Nov 1, 2016

Study Results

No Results Posted as of Nov 9, 2016